Rob J.P.M. Scholten is senior researcher at the Julius Center for Health Sciences and Primary Care. Since 2001, he is the director of The Dutch Cochrane Centre which is hosted by the Julius Center.
Rob did his medical training at the Vrije Universiteit in Amsterdam and in 1993 he obtained his PhD in Clinical Epidemiology at the same university (Thesis ‘The increased incidence of meningococcal disease in the Netherlands: an attempt at an epidemiological explanation’). In 1995 he was formally registered as Clinical Epidemiologist (‘Wetenschappelijk Onderzoeker Epidemioloog’, SMBWO).
From 1993 to 2000 Rob worked as senior researcher of the research programme “Musculoskeletal disorders” of the EMGO-Institute, Amsterdam, and from 2000 to 2013 as Senior Clinical Epidemiologist at The Dutch Cochrane Centre and the department of Clinical Epidemiology, Biostatistics and Bioinformatics of the Academic Medical Center in Amsterdam. In 2001 he became the director of the Dutch Cochrane Centre and in 2010, he was appointed as Professor of Clinical Epidemiology in particular Evidence-based Medicine at the University of Amsterdam.
Interests and Focus
Rob’s research focuses on three main areas: 1) Developing and refining methods for systematic reviews and meta-analysis; 2) Selective publication and selective outcome reporting; and 3) Methods to improve the interpretation and presentation of systematic review results.
Rob collaborates with various national and international researchers. With respect to the theme ‘Selective publication and selective outcome reporting’ many research projects arise from the Netherlands Trial Register (NTR), that is hosted by the Dutch Cochrane Centre since 2004. This register had been approved by the WHO as primary register. This register forms a rich source for research projects.
Rob participates actively in the international GRADE Working Group. The development of better presentation and interpretation of results of diagnostic studies and better formats for presenting those results to end-users of diagnostic reviews are one of the key activities.
Endorsement of ICMJE's Clinical Trial Registration Policy: a survey among journal editors
Hooft L, Korevaar DA, Molenaar N, Bossuyt PM, Scholten RJ
Neth J Med,
Endoscopic release for carpal tunnel syndrome
Vasiliadis HS, Georgoulas P, Shrier I, Salanti G, Scholten RJ
Cochrane Database Syst Rev,
2014 Jan 31;1:CD008265. doi: 10.1002/14651858.CD008265.pub2
Investigation of publication bias in meta-analyses of diagnostic test accuracy: a meta-epidemiological study
van Enst WA, Ochodo E, Scholten RJ, Hooft L, Leeflang MM
BMC Med Res Methodol,
2014 May 23;14(1):70. doi: 10.1186/1471-2288-14-70
Trial registration numbers are underreported in biomedical publications
van de Wetering FT, Scholten RJ, Haring T, Clarke M, Hooft L
2012;7(11):e49599. doi: 10.1371/journal.pone.0049599
Continuous glucose monitoring systems for type 1 diabetes mellitus
Langendam MW, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ
Cochrane Database Syst Rev,
2012 Jan 18;1:CD008101. doi: 10.1002/14651858.CD008101.pub2
All Pubmed publications